BAX and cancer: Additionally, 17-AAG induces apoptosis by promoting the mitochondrial release of cytochrome C and Smac/DIABLO, activating caspase-9 and caspase-3, and causing a conformational change in Bax, underscoring its potential therapeutic uses in cancer treatment [33].